Delivery Order SPE2DR25D1052-SPE2DR26F6CH2
- Not listed
- The Defense Logistics Agency awarded a $13,973.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Scemblix 40 mg tablets (60-count unit of use packaging). This non-set-aside contract is scheduled for completion by December 22, 2025, and represents a single delivery order fulfillment from AmerisourceBergen's extensive pharmaceutical supply portfolio. The place of performance is located at the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $27,946.94 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on December 4, 2025, with an ultimate completion date of December 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $27,946.94 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on November 18, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $98,000 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This competitive, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 26, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a $13,973.47 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation, reflecting AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,259.50 on November 6, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Scemblix 40 mg tablets (60-count units) with a ceiling value of $26,519.00. This firm fixed-price delivery order, with an ultimate completion date of November 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Scemblix 40 mg tablets (60-count units) with a contract ceiling value of $39,778.50. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The contract is set to be completed by September 17, 2025, and performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Scemblix 40 mg tablets (60-count unit doses) with a ceiling value of $13,259.50. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6CH2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,973.47 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This firm fixed-price delivery order, with a completion deadline of December 31, 2025, represents a competitive, non-set-aside award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems and other federal customers worldwide. The company's federal contracting portfolio demonstrates consistent success in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, positioning it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 12/8/25 |